(PRDS) – Hot Corp. News
-
Pardes Biosciences (PRDS) to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights
-
Pardes Biosciences (PRDS) Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19
Back to PRDS Stock Lookup
